These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16871675)

  • 1. [Monitorized use of 18FDG positron emission tomography].
    Rodríguez Garrido M; Asensio del Barrio C
    Rev Esp Med Nucl; 2006; 25(3):217-20. PubMed ID: 16871675
    [No Abstract]   [Full Text] [Related]  

  • 2. Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer.
    Bury T; Dowlati A; Paulus P; Corhay JL; Hustinx R; Ghaye B; Radermecker M; Rigo P
    Eur Respir J; 1997 Nov; 10(11):2529-34. PubMed ID: 9426090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.
    Antoch G; Saoudi N; Kuehl H; Dahmen G; Mueller SP; Beyer T; Bockisch A; Debatin JF; Freudenberg LS
    J Clin Oncol; 2004 Nov; 22(21):4357-68. PubMed ID: 15514377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [FDG-PET (positron emission tomography) in the detection of primary breast cancer and lymph node involvement].
    Koga S; Nakano S; Honma Y; Ogasawara N
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():379-84. PubMed ID: 17682181
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of positron emission tomography (PET) imaging in disease staging and therapy assessment.
    Jerusalem G; Hustinx R; Beguin Y; Fillet G
    Ann Oncol; 2002; 13 Suppl 4():227-34. PubMed ID: 12401695
    [No Abstract]   [Full Text] [Related]  

  • 6. [Positron emission tomography (PET) in clinical oncology. Part II].
    Cabrera Villegas A; Gámez Cenzano C; Martín Urreta JC
    Rev Esp Med Nucl; 2002 Apr; 21(2):131-47; quiz 149-51. PubMed ID: 11879626
    [No Abstract]   [Full Text] [Related]  

  • 7. Oncological applications of FDG PET imaging.
    Delbeke D
    J Nucl Med; 1999 Oct; 40(10):1706-15. PubMed ID: 10520713
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quality control of PET imaging: from study to diagnosis].
    Daisaki H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2012; 68(7):916-25. PubMed ID: 22821167
    [No Abstract]   [Full Text] [Related]  

  • 9. Dual time point 2-deoxy-2-[18F]fluoro-D-glucose PET/CT: nodal staging in locally advanced breast cancer.
    García Vicente AM; Soriano Castrejón A; Cruz Mora MÁ; Ortega Ruiperez C; Espinosa Aunión R; León Martín A; González Ageitos A; Van Gómez López O
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):1-5. PubMed ID: 23707190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography (PET) in the evaluation of patients with cancer.
    Godwin HA; Zuger JH
    Trans Am Clin Climatol Assoc; 1999; 110():181-94. PubMed ID: 10344016
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluorodeoxyglucose positron emission tomography for the preoperative staging of oral cavity cancers: only one piece of the puzzle.
    Waldron JN
    J Clin Oncol; 2006 Sep; 24(27):4367-8. PubMed ID: 16983103
    [No Abstract]   [Full Text] [Related]  

  • 12. 18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study.
    Hitier-Berthault M; Ansquer C; Branchereau J; Renaudin K; Bodere F; Bouchot O; Rigaud J
    Int J Urol; 2013 Aug; 20(8):788-96. PubMed ID: 23279605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is FDG-PET indicated for superficial esophageal cancer?
    Little SG; Rice TW; Bybel B; Mason DP; Murthy SC; Falk GW; Rybicki LA; Blackstone EH
    Eur J Cardiothorac Surg; 2007 May; 31(5):791-6. PubMed ID: 17337344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of 18F-FDG-PET in breast cancer imaging].
    Tayama K; Toh U; Fujii T; Shirouzu K; Kaida Y
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():373-8. PubMed ID: 17679209
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of FDG-PET imaging in the management of lymphoma.
    Kostakoglu L; Leonard JP; Coleman M; Goldsmith SJ
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):115-21. PubMed ID: 16163171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
    Halter G; Buck AK; Schirrmeister H; Wurziger I; Liewald F; Glatting G; Neumaier B; Sunder-Plassmann L; Reske SN; Hetzel M
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1093-9. PubMed ID: 15052207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical application of positron emission tomography and 18FDG to brain tumor].
    Momose T
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():242-9. PubMed ID: 16201530
    [No Abstract]   [Full Text] [Related]  

  • 18. Is 18FDG PET/CT evaluation really useful in the diagnosis of elastofibroma dorsi?
    Lococo F; Cesario A; de Franco S; Ricchetti T; Sgarbi G; Treglia G
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):62. PubMed ID: 24360600
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycosis fungoides involving the lungs detected by (18)F-FDG PET/CT.
    Treglia G; Barizzi J; Giovanella L
    Arch Bronconeumol; 2015 Oct; 51(10):521-2. PubMed ID: 25666297
    [No Abstract]   [Full Text] [Related]  

  • 20. [Non-Hodgkin's lymphoma staging: a prospective study of the value of positron emission tomography/computed tomography (PET/CT) versus PET and CT].
    Rodríguez-Vigil Junco B; Gómez León N; Pinilla Fernández I; del Campo L; Hernández Maraver D; Coya J
    Med Clin (Barc); 2011 Oct; 137(9):383-9. PubMed ID: 21703647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.